INBS: the balance sheet

MyFinsight

For the quarter ending 2025-09-30, INBS has $10,038,309 in assets. $6,611,380 in debts. $1,660,105 in cash and cash equivalents.

Unit: Dollar

Balance Sheets	2025-09-30
Cash and cash equivalents	1,660,105
Accounts receivable, net	717,823
Inventories	628,177
Research and development tax incentive receivable	924,062
Assets held for sale	66,020
Other current assets	488,182
Total current assets	4,484,369
Property and equipment, net	271,745
Operating lease right-of-use assets	1,808,892
Intangibles, net	3,473,303
Total assets	10,038,309

Accounts payable and accrued expenses	3,992,427
Current portion of operating lease liabilities	362,801
Current employee benefit liabilities	567,059
Notes payable	139,787
Total current liabilities	5,062,074
Employee benefit liabilities, less current portion	100,041
Operating lease liabilities, less current portion	1,449,265
Total liabilities	6,611,380
Common stock, 0.01 par value, 100,000,000 shares authorized, 9,098,473 and 9,098,357 shares issued and outstanding, respectively, as of september 30, 2025 7,323,377 and 7,323,261 shares issued and outstanding, respectively, as of june 30, 2025	90,985
Treasury stock, at cost, 116 shares as of september 30, 2025 and june 30, 2025	1
Additional paid-in capital	69,325,542
Accumulated deficit	-65,516,071
Accumulated other comprehensive loss	-279,228
Total consolidated intelligent bio solutions inc. equity	3,621,227
Non-controlling interest	-194,298
Total shareholders equity	3,426,929
Total liabilities and shareholders equity	10,038,309